MCM5 and central nervous system cancer: Compared to the HMOX1-wildtpe group, HMOX1-mutant group shared significantly higher mutation frequencies of TP53, TTN, MCM5 in pan-cancers (Supplementary Figure 3C), and higher mutation frequencies of MCM5, APOL6, MB in lower grade gliomas (Supplementary Figure 3D).